A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Dr Paul T. Menzel joins Ethics Talk to discuss his article: "How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom?"
Christopher W. Reynolds joins Ethics Talk to discuss his article, coauthored with Camilo Sánchez Meertens: “How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants?”
This article considers 1990s and 2000s-era civil rights complaints in NYC and offers legal strategies for scaling health outcomes improvement nationwide.
AMA J Ethics. 2023;25(1):E48-54. doi:
10.1001/amajethics.2023.48.
Jing Li, PhD, Robert Tyler Braun, PhD, Sophia Kakarala, and Holly G. Prigerson, PhD
For dying patients and their loved ones to make informed decisions, physicians must share adequate information about prognoses, prospective benefits and harms of specific interventions, and costs.
AMA J Ethics. 2022;24(11):E1040-1048. doi:
10.1001/amajethics.2022.1040.